Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference
December 07, 2017 16:05 ET
|
OptiNose, Inc.
YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose Reports Third Quarter 2017 Financial Results and Recent Operating Highlights
November 27, 2017 16:05 ET
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported...
Optinose to Report Third Quarter 2017 Financial Results and Operational Highlights on November 27, 2017
November 20, 2017 07:30 ET
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that the Company will...
Optinose to Present at Piper Jaffray Healthcare Conference
November 17, 2017 07:30 ET
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose to Present at Jefferies 2017 London Healthcare Conference
November 08, 2017 08:00 ET
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose Expands Leadership Team with Key Hires
October 30, 2017 08:00 ET
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced the addition of five key...
Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
October 17, 2017 16:01 ET
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by...
Optinose Announces Pricing of Initial Public Offering
October 12, 2017 21:17 ET
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 12, 2017 (GLOBE NEWSWIRE) -- OptiNose, Inc. (Optinose), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by...